Company Description
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indicati...
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company's predecessor was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in Burlingame, CA.
Valuation
Price to Book Ratio
2.40
Enterprise Value to EBITDA
-0.41
Efficiency
Liquidity
Current Ratio
24.00
Quick Ratio
24.00
Cash Ratio
23.78
Profitability
Return on Assets
-20.45
Return on Equity
-21.05
Return on Total Capital
-19.83
Capital Structure
Total Debt to Total Assets
0.68
Officers and Executives
Name | Age | Officer Since | Title |
---|---|---|---|
Dr. Jaume Pons | 54 | 2015 | President, Chief Executive Officer & Director |
Dr. Michael Chang | - | 2015 | Vice President-Operations |
Mr. Peter S. García | 58 | 2020 | Chief Financial Officer |
Dr. Sophia Randolph | 52 | 2016 | Chief Medical Officer |
Mr. Hank Stern | - | 2015 | Vice President-Chemistry, Manufacturing & Controls |
Insider Actions
02/07/2022 |
Peter S. García Chief Financial Officer |
8,363 | Derivative/Non-derivative trans. at $4.81 per share. | 40,226 |
02/07/2022 |
Peter S. García Chief Financial Officer |
6,637 | Derivative/Non-derivative trans. at $4.08 per share. | 27,078 |
02/03/2022 |
Jaume Pons President & CEO; Director |
12,254 | Derivative/Non-derivative trans. at $1.91 per share. | 23,405 |
02/03/2022 |
Jaume Pons President & CEO; Director |
11,900 | Derivative/Non-derivative trans. at $0.99 per share. | 11,781 |
01/28/2022 |
Shelly Pinto VP, Finance and CAO |
50,000 | Award at $0 per share. | 0 |
12/15/2021 |
Sophia Randolph Chief Medical Officer; Director |
11,059 | Derivative/Non-derivative trans. at $1.91 per share. | 21,122 |
12/15/2021 |
Sophia Randolph Chief Medical Officer; Director |
12,793 | Derivative/Non-derivative trans. at $0.99 per share. | 12,665 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
60 | Disposition at $30.23 per share. | 1,813 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
440 | Disposition at $30.23 per share. | 13,301 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
181 | Disposition at $29.6 per share. | 5,357 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,329 | Disposition at $29.6 per share. | 39,338 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
299 | Disposition at $28.37 per share. | 8,482 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
2,196 | Disposition at $28.37 per share. | 62,300 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,296 | Disposition at $27.49 per share. | 35,627 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
9,509 | Disposition at $27.49 per share. | 261,402 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
2,339 | Disposition at $26.48 per share. | 61,936 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
17,169 | Disposition at $26.48 per share. | 454,635 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,627 | Disposition at $25.29 per share. | 41,146 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
11,945 | Disposition at $25.29 per share. | 302,089 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
60 | Disposition at $30.23 per share. | 1,813 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
440 | Disposition at $30.23 per share. | 13,301 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
181 | Disposition at $29.6 per share. | 5,357 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,329 | Disposition at $29.6 per share. | 39,338 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
299 | Disposition at $28.37 per share. | 8,482 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
2,196 | Disposition at $28.37 per share. | 62,300 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,296 | Disposition at $27.49 per share. | 35,627 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
286,496 | Disposition at $27.49 per share. | 7,875,775 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
2,339 | Disposition at $26.48 per share. | 61,936 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
17,169 | Disposition at $26.48 per share. | 454,635 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,627 | Disposition at $25.29 per share. | 41,146 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
11,945 | Disposition at $25.29 per share. | 302,089 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
12 | Disposition at $32.16 per share. | 385 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
88 | Disposition at $32.16 per share. | 2,830 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
2,172 | Disposition at $31.55 per share. | 68,526 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
15,942 | Disposition at $31.55 per share. | 502,970 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
967 | Disposition at $30.77 per share. | 29,754 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
7,093 | Disposition at $30.77 per share. | 218,251 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
12 | Disposition at $32.16 per share. | 385 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
88 | Disposition at $32.16 per share. | 2,830 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
2,172 | Disposition at $31.55 per share. | 68,526 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
15,942 | Disposition at $31.55 per share. | 502,970 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
967 | Disposition at $30.77 per share. | 29,754 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
7,093 | Disposition at $30.77 per share. | 218,251 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,911 | Disposition at $32.73 per share. | 62,547 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
14,028 | Disposition at $32.73 per share. | 459,136 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
5,751 | Disposition at $32.06 per share. | 184,377 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
42,203 | Disposition at $32.06 per share. | 1,353,028 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,560 | Disposition at $31.08 per share. | 48,484 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
11,452 | Disposition at $31.08 per share. | 355,928 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,911 | Disposition at $32.73 per share. | 62,547 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
14,028 | Disposition at $32.73 per share. | 459,136 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
5,751 | Disposition at $32.06 per share. | 184,377 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
42,203 | Disposition at $32.06 per share. | 1,353,028 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,560 | Disposition at $31.08 per share. | 48,484 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
11,452 | Disposition at $31.08 per share. | 355,928 |
12/08/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
208 | Disposition at $33.8 per share. | 7,030 |
12/08/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,531 | Disposition at $33.8 per share. | 51,747 |
12/08/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
4,883 | Disposition at $33.23 per share. | 162,262 |
12/08/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
35,836 | Disposition at $33.23 per share. | 1,190,830 |
12/08/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
208 | Disposition at $33.8 per share. | 7,030 |
12/08/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,531 | Disposition at $33.8 per share. | 51,747 |
12/08/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
4,883 | Disposition at $33.23 per share. | 162,262 |
12/08/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
35,836 | Disposition at $33.23 per share. | 1,190,830 |
11/22/2021 |
Sophia Randolph Chief Medical Officer; Director |
14,884 | Disposition at $36.77 per share. | 547,284 |
11/22/2021 |
Sophia Randolph Chief Medical Officer; Director |
30,000 | Derivative/Non-derivative trans. at $4.08 per share. | 122,400 |
10/18/2021 |
Peter S. García Chief Financial Officer |
189 | Disposition at $59.06 per share. | 11,162 |
10/18/2021 |
Peter S. García Chief Financial Officer |
438 | Disposition at $58.3 per share. | 25,535 |
10/18/2021 |
Peter S. García Chief Financial Officer |
411 | Disposition at $57.54 per share. | 23,648 |
10/18/2021 |
Peter S. García Chief Financial Officer |
1,437 | Disposition at $56.09 per share. | 80,601 |
10/18/2021 |
Peter S. García Chief Financial Officer |
1,903 | Disposition at $55.15 per share. | 104,950 |
10/18/2021 |
Peter S. García Chief Financial Officer |
2,851 | Disposition at $54.33 per share. | 154,894 |
10/18/2021 |
Peter S. García Chief Financial Officer |
7,229 | Derivative/Non-derivative trans. at $4.08 per share. | 29,494 |
MarketWatch News on ALXO
-
ALX Oncology stock price target cut to $36 from $60 at Stifel Nicolaus
- Tomi Kilgore
-
ALX Oncology initiated at buy with $106 target price at Stifel
- Tonya Garcia
-
ALX Oncology started at buy with $96 stock price target at UBS
- Tomi Kilgore
-
Biotech stocks are a buy — especially these 18 picks
- Michael Brush
-
ALX Oncology sets IPO terms, to raise up to $136 million
- Tomi Kilgore
Other News on ALXO
-
ALX Oncology files for $450 mixed shelf offering
- Seeking Alpha
-
10-K: ALX ONCOLOGY HOLDINGS INC
- Edgar Online - (EDG = 10Q, 10K)
-
ALX Oncology Is Turning Into An Also-Ran In Anti-CD47
- Seeking Alpha
-
New Strong Sell Stocks for January 19th
- Zacks.com
-
ALX Oncology plunges as director sells shares worth $75M
- Seeking Alpha
-
ALX Oncology under pressure as director sells shares worth $4.7M
- Seeking Alpha
-
RENN, VIOT and IGMS among mid-day movers
- Seeking Alpha
-
ALX Oncology Holdings (ALXO) Investor Presentation
- Seeking Alpha
-
10-Q: ALX ONCOLOGY HOLDINGS INC
- Edgar Online - (EDG = 10Q, 10K)
-
Warning: ALXO is at high risk of performing badly
- Seeking Alpha
-
AGC, QUBT and BTB among mid-day movers
- Seeking Alpha
-
JP, HCDI and PETZ among mid-day movers
- Seeking Alpha
- Loading more headlines...